市場調查報告書

全球免標定檢測(LFD)市場:成長,趨勢,及預測(2019年∼2024年)

Global Label-Free Detection (LFD) Market - Growth, Trends, and Forecasts (2020 - 2025)

出版商 Mordor Intelligence LLP 商品編碼 707240
出版日期 內容資訊 英文 111 Pages
商品交期: 2-3個工作天內
價格
全球免標定檢測(LFD)市場:成長,趨勢,及預測(2019年∼2024年) Global Label-Free Detection (LFD) Market - Growth, Trends, and Forecasts (2020 - 2025)
出版日期: 2020年08月01日內容資訊: 英文 111 Pages
簡介

本報告提供全球免標定檢測市場的相關調查,市場機會和趨勢,成長及阻礙因素,各產品、技術、用途、終端用戶、地區的市場分析,競爭情形,主要企業的簡介等資訊。

目錄

第1章 簡介

  • 調查成果
  • 調查的前提條件
  • 調查範圍

第2章 調查方法

第3章 摘要整理

第4章 市場動態

  • 市場概況
  • 成長要素
  • 阻礙因素
  • 波特的五力分析
    • 新加入廠商的威脅
    • 買主/消費者談判力
    • 供應商談判力
    • 替代產品的威脅
    • 產業內的競爭

第5章 市場區隔

  • 各產品
    • 消耗品
    • 設備
  • 各技術
    • 質譜分析
    • 表面電漿子共振(SPR)
    • 生物薄膜干涉技術
    • 等溫滴定熱量檢測
    • 差示掃描量熱法
    • 其他
  • 各用途
    • 結合動力學
    • 結合熱力學
    • 內因性受體的檢測
    • 擊中確認
    • 潛在客戶開發
    • 其他
  • 各終端用戶
    • 製藥、生物科技企業
    • 學術研究機關
    • 受託研究機構
  • 各地區
    • 北美
    • 歐洲
    • 亞太地區
    • 中東、非洲
    • 南美

第6章 競爭情形

  • 企業簡介
    • Ametek Inc.
    • Corning Incorporated
    • Danaher Corporation
    • General Electric Company
    • Horiba Ltd.
    • Malvern Panalytical
    • PerkinElmer Inc.
    • 株式會社島津製作所
    • Thermo Fisher Scientific
    • Fluidic Analytics

第7章 市場機會及今後趨勢

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: 64027

The Global Label-Free Detection (LFD) Market is expected to register a CAGR of 8.5% during the forecast period. The main advantage in LFD techniques is that more direct information can be acquired as the method uses only native proteins and ligands. Innovations in LFD techniques include modification of mass spectrometry to develop surface-enhanced laser desorption/ionization (SELDI) time of flight (TOF)- mass spectrometry (MS) which is an innovative approach that offers on-chip purification of the proteins of interest and subsequent ionization of the retained molecules to be detected. Other innovations in LFD techniques include the modification of surface plasmon resonance (SPR) to develop Localized Surface Plasmon Resonance (LSPR) which provides advantages like lower fabrication costs and higher sensitivity. As per Pfizer Inc, annual report 2019, Pfizer's expenditures on research and development (R&D) in 2019 was around USD 8.65 billion. This was an increase compared to 2018 which was about USD 8.1 billion. Furthermore, with the introduction of new innovations in the label-free detection technologies the market is expected to experience significant growth.

Key Market Trends

Surface Plasmon Resonance (SPR) Segment is Expected to Hold Largest Share of Global Label-Free Detection (LFD) Market

  • Based on technology used, surface plasmon resonance (SPR) technology segment is expected to hold significant market share in the global label-free detection market due to its wide application range and compatibility with a wide range of biomolecules. However, the bio-layer interferometry segment is expected to grow at the fastest rate over the forecast period.
  • According to the National Institutes for Health (NIH), total clinical research funding by the National Institutes for Health (NIH) in 2017, 2018 and 2019 was USD 12,695 million, USD 13,870 million, and USD 15,023 million. As clinical research funding increasing which will boost the market in the near future. Furthermore, interferometry provides advantages like less fluctuation in the refractive index of the samples being tested and microfluidic-free nature of bio-layer interferometry label-free detection systems. Hence, owing to above all factors the segment is expected to show growth over the forecast period.

North America Region Holds the Largest Market Share of Label-Free Detection (LFD) Market

North America dominates the global label-free detection market due to technological advancement and high government funding in the region. Also, increasing prevalence of disease and the growth in drug discovery programs in the region. According to the National Clinical Trials Registry (NCT), in 2019, the number of registered clinical studies alone in the United States was around 108,790. Furthermore, partnerships between pharmaceutical companies and academic institutes and the presence of several pharmaceutical and biotechnological companies will also augment the growth of the market.

Competitive Landscape

The Label-Free Detection (LFD) Market is fragmented competitive and consists of several major players. The companies are implementing certain strategic initiatives such as merger, new product launch, acquisition and partnerships that help them in strengthening their market position. Further, these leaders have products for all the end users, a strong grographical presence and also focusing on product innovations.

Reasons to Purchase this report:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 Study Deliverables
  • 1.2 Study Assumptions
  • 1.3 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Increasing R&D Activities Through Research Partnerships Between Pharmaceutical Companies and Academic Institutes
    • 4.2.2 Innovations in Label-free Detection Technologies
  • 4.3 Market Restraints
    • 4.3.1 High Cost of Instruments
    • 4.3.2 Issues in Sensitivty and Throughput
  • 4.4 Porter's Five Force Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION

  • 5.1 By Product
    • 5.1.1 Consumables
      • 5.1.1.1 Biosensor Chips
      • 5.1.1.2 Microplates
    • 5.1.2 Instruments
  • 5.2 By Technology
    • 5.2.1 Mass Spectrometry
    • 5.2.2 Surface Plasmon Resonance (SPR)
    • 5.2.3 Bio-Layer Interferometry
    • 5.2.4 Isothermal Titration Calorimetry
    • 5.2.5 Differential Scanning Calorimetry
    • 5.2.6 Other Lfd Technologies
  • 5.3 By Application
    • 5.3.1 Binding Kinetics
    • 5.3.2 Binding Thermodynamics
    • 5.3.3 Endogenous Receptor Detection
    • 5.3.4 Hit Confirmation
    • 5.3.5 Lead Generation
    • 5.3.6 Other Applications
  • 5.4 By End-User
    • 5.4.1 Pharmaceutical & Biotechnology Companies
    • 5.4.2 Academic & Research Institutes
    • 5.4.3 Other End-Users
  • 5.5 Geography
    • 5.5.1 North America
      • 5.5.1.1 United States
      • 5.5.1.2 Canada
      • 5.5.1.3 Mexico
    • 5.5.2 Europe
      • 5.5.2.1 Germany
      • 5.5.2.2 United Kingdom
      • 5.5.2.3 France
      • 5.5.2.4 Italy
      • 5.5.2.5 Spain
      • 5.5.2.6 Rest of Europe
    • 5.5.3 Asia-Pacific
      • 5.5.3.1 China
      • 5.5.3.2 Japan
      • 5.5.3.3 India
      • 5.5.3.4 Australia
      • 5.5.3.5 South Korea
      • 5.5.3.6 Rest of Asia-Pacific
    • 5.5.4 Middle-East and Africa
      • 5.5.4.1 GCC
      • 5.5.4.2 South Africa
      • 5.5.4.3 Rest of Middle-East and Africa
    • 5.5.5 South America
      • 5.5.5.1 Brazil
      • 5.5.5.2 Argentina
      • 5.5.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Ametek Inc.
    • 6.1.2 Corning Incorporated
    • 6.1.3 Cytiva (GE Healthcare)
    • 6.1.4 Horiba Ltd.
    • 6.1.5 Malvern Panalytical
    • 6.1.6 PerkinElmer Inc.
    • 6.1.7 Shimadzu Corporation
    • 6.1.8 Thermo Fisher Scientific
    • 6.1.9 Fluidic Analytics

7 MARKET OPPORTUNITIES AND FUTURE TRENDS